Flashcards in Placenta accreta spectrum Deck (15)
Risk factors for accreta
- Previous history of accreta
- Previous caesarean delivery/ other uterine surgery. Risk increases as the number of prior CS increases.
Previous caesarean delivery and the presence of an anterior low-lying placenta or placenta praevia should alert the antenatal care team of the higher risk of placenta accreta spectrum and women should be specifically screened for accreta
Accuracy of USS for diagnosing accreta?
Highly accurate when TV scan performed by a skilled operator with experience in diagnosing placenta accreta spectrum
Should be scanned in a unit with scanning expertise
Under these circumstances it is comparable to MRI
Management of accreta
Antenatal diagnosis crucial
Optimise Hb antenatally
- General caesarean section risks
- Specific risks: massive obstetric haemorrhage, lower urinary tract damage, blood transfusion, hysterectomy
Discuss blood products and consider cell salvage and interventional radiology
Delivery- most senior team available
Role of MRI in accreta
The diagnostic value of MRI and ultrasound imaging is similar when performed by experts.
MRI can complement ultrasound by assessing:
1. Depth of invasion
2. Lateral extension of myometrial invasion, especially with posterior placentation and/or in women with ultrasound signs suggesting parametrial invasion.
Timing of delivery
If no risk factors for preterm delivery aim for 35+0 to 36+6
A contingency plan for emergency delivery should be developed
Delivery in a centre with facilities for complex surgery and peripartum hysterectomy
Consenting for CS for accreta
Massive obstetric haemorrhage,
increased risk of lower urinary tract damage,
Talk about cell salvage and IR
Surgical approach to CS
- Skilled operator
1. Delivery of the baby and attempted delivery of the placenta. High likelihood of hysterectomy and bleeding.
2. Delivery of the baby via a uterine incision distant from the placenta, quick repair of the uterus and en bloc hysterectomy.
3. Delivery of the baby via a uterine incision distant from the placenta, repair the uterus and conservative management.
- Preferable to perform hysterectomy and leave placenta in situ
- Can consider ureteric stents. Not evidence based.
Uterus conserving approach to management of accreta
What are the risks?
-Leave placenta in situ and close uterus
- Post op care: regular review, ultrasound examination
- Women need access to emergency care in case of complications such as bleeding or infection
- No evidence for methotrexate
Risks: secondary hysterectomy (30%), infection, bleeding, mortality (3.7%), in up to 70% of women (small study) they were able to conceive again
Definition of accreta spectrum
Spectrum- ranges from morbidly adherent to deeply invasive placenta
Accreta: where the villi adheres superficially to the myometrium without interposing decidua;
Increta: where the villi penetrate deeply into the uterine myometrium down to the serosa
Percreta: the villous tissue perforates through the entire uterine wall and may invade the surrounding pelvic organs, such as the bladder
Incidence of accreta
Between 1:300 and 1:2000
USS features of placenta accreta
2D greyscale signs:
Loss of the ‘clear zone’ (i.e. abscence of decidua basalis)
Abnormal placental lacunae
Bladder wall interruption
Focal exophytic mass
Doppler: hypervascularity and turbulent blood flow extending from placenta into surrounding tissues
MRI features of placenta accreta
- Uterine bulging,
- intraplacental bands,
- Heterogeneous placenta,
- Disorganised vasculature of placenta
- Focal interruptions of the endometrial myometrial border
Surgical management for percreta
1. Primary hysterectomy following delivery of the fetus, without attempting placental separation.
2. Delivery of the fetus avoiding the placenta, with repair of the incision leaving the placenta in situ
3. Delivery of the fetus without disturbing the placenta, followed by partial excision of the uterine wall (placental implantation site) and repair of the uterus.
4. Delivery of the fetus without disturbing the placenta, and leaving it in situ, followed by elective secondary
hysterectomy 3–7 days following the primary procedure
No evidence to strongly support each method. Conservative approach not recommended due to very high (nearly 60% risk) of requiring secondary hysterectomy, and significant infectious morbidity.
Also consider cystoscopy and ureteric stents prior to surgery if suspicion of bladder invasion
Risk of accreta spectrum with a known LLP/praevia by increasing number of CS?
CS increases the risk of placenta accreta spectrum 7 fold
0 CS = 3.3 - 4%
>/= 3 CS = 50 - 67%